GSL Synthetase Inhibitor Eliglustat Combined With CD30 Target Immunotherapy for the Treatment of of CD30+ Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Serum Histone Succinylation as a Novel Prognostic Biomarker in Hematological Malignancies
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Odronextamab in Low Tumor Volume Advanced FL
- Status
- RECRUITING
- Phase
- PHASE2
A Phase I Dose Finding Study of MB-CART2219.1
- Status
- RECRUITING
- Phase
- PHASE1
A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Study of Targeted CD22/CD19 CAR-T Therapy for First-line Consolidation of B-cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Cardiovascular Risk in Children With Chronic Conditions Study
- Status
- RECRUITING
- Phase
- N/A
TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas
- Status
- RECRUITING
- Phase
- PHASE1
Immune Reconstitution Monitoring and Pneumococcal Vaccination in Patients Treated With CAR-T Cells
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)
- Status
- RECRUITING
- Phase
- NA
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
- Status
- RECRUITING
- Phase
- NA
Mosunetuzumab for CLL MRD Clearance
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
CD30 CAR-T in the Treatment of CD30 Positive Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study IV
- Status
- RECRUITING
- Phase
- N/A
A Study of Epcoritamab With Lenalidomide and Tafasitamab in People With Diffuse Large B Cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE2
The PACMAN-Hu19 Trial: a Study of the Safety and Feasibility of Locally Produced, CD19-targeted and Human CAR T-cell Therapy in Children and Young Adults With Relapsed or Refractory B-cell Malignancies
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors
- Status
- RECRUITING
- Phase
- NA
A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Phase I/II Clinical Study of CTS3497 in Patients With MTAP Deficient Malignacies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2